This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Bioinformatics Remove Clinical Development Remove RNA Related Topics
Bioassay In-Vivo Reagent DNA Gene Editing Life Science Protein Antibody Immune Response Gene More Related Topics >
article thumbnail

Reflecting on PEGS Europe 2023 

Drug Discovery World

NOVEMBER 30, 2023

Field also covered the capabilities and strategies that enable acceleration of Fc-fusion, Fab fragment and bispecific antibodies through pre-clinical development. It was presented by Xiaole Shirley Liu, PhD, CEO, GV20 Therapeutics, and titled: ‘AI-based target and antibody discovery from patient tumour profiles’.

Antibody 59
Antibody Protein Engineer In-Vivo 59
article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

NOVEMBER 13, 2023

Novel/alternative ML-enabled screening technologies for higher POS Following chairperson’s remarks from M Frank Erasmus, PhD, Head, Bioinformatics, Specifica, there will be four presentations and a panel discussion. Jana Langhoff, Tecan, on: ‘Opportunities and challenges of automating high throughput protein purification’.

Protein 59
Protein Antibody Engineer Scientist 59
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024